Stem Cell Preservation Technologies Inc – REVENUE SHARING AGREEMENT (November 26th, 2002)
EXHIBIT 10.3 REVENUE SHARING AGREEMENT This REVENUE SHARING AGREEMENT is made as of the 3/rd/ day of October, 2002, between Stem Cell Preservation Technologies, Inc. ("Company") and CRYO-CELL International Inc. ("Purchaser"). Preamble WHEREAS, Company stores stem cell specimens for its customers ("Primary Stored Specimens") and charges its customers a fee for such storage, as well as a fee for storage of stem cell specimens from the same customer for backup purposes ("Secondary Specimens"); and WHEREAS, Purchaser desires to purchase the opportunity to share in revenues received by Company with respect to Primary Stored Specimens received from residents of the States of Illinois and New York. ACCORDINGLY, in consideration of the mutual covenants contained herein, and for other valuable consideration, the receipt and suffi
Stem Cell Preservation Technologies Inc – SECONDARY STORAGE AGREEMENT (November 26th, 2002)
Exhibit 10.2 SECONDARY STORAGE AGREEMENT This Agreement, by and between Safti-Cell, Inc., its successors or assigns (SCI) and Stem Cell Preservation Technologies, Inc. (SCPT), witnesses that: Whereas SCPT is engaged in the business of preservation of adult stem sells and preserves such cells at a primary storage location in Clearwater, Florida, USA, and: Whereas SCI is committed to building a future, state-of-the-art, secure, fire-resistant, earthquake-resistant facilities for the storage of such cells, now THEREFORE, upon receipt of $10.00 and other good and valuable consideration which the parties hereby acknowledge, it is agreed that: 1. SCPT will deliver cryopreserved second units of cells, to SCI for secondary, backup storage. 2. SCI will maintain the storage of such cells in a secure cryogenic environment. 3.
Stem Cell Preservation Technologies Inc – 2002 STOCK OPTION AND EQUITY COMPENSATION PLAN (November 26th, 2002)
EXHIBIT 10.4 STEM CELL PRESERVATION TECHNOLOGIES, INC. 2002 STOCK OPTION AND EQUITY COMPENSATION PLAN 1. GRANT OF RESTRICTED STOCK AND EQUITY COMPENSATION OPTIONS; GENERALLY. In accordance with the provisions hereinafter set forth in this stock option plan, the name of which is the STEM CELL PRESERVATION TECHNOLOGIES, INC. Amended and Restated 2002 STOCK OPTION AND EQUITY COMPENSATION PLAN (the "Plan"), the Board of Directors (the "Board") or the Compensation Committee (the "Committee") of Stem Cell Preservation Technologies, Inc. (the "Corporation") is hereby authorized to issue from time to time on the Corporation's behalf to any one or more Eligible Persons, as hereinafter defined, restricted stock or options to acquire shares of the Corporation's $.0001 par value common stock (the "Stock"). The Committee shall have the sole authority to (i) determine the individua
Stem Cell Preservation Technologies Inc – AGREEMENT (June 3rd, 2002)
Exhibit 10.1 AGREEMENT By and between Stem Cell Preservation Technologies, Inc. ("SCPT") and CRYO- CELL International, Inc. ("CCEL"). Whereas, CCEL is in the business of processing and storage of stem cells for preservation; and Whereas, SCPT is desirous of marketing the preservation of stem cells for tomorrow's technology for mutual consideration between the parties and the payment of $10.00 (Ten Dollars) cash in hand, which is hereby acknowledged, it is agreed: 1. SCPT will expend all necessary marketing costs for developing storage clientele, except for newborn babies, at no cost to CRYO-CELL. (Except if a contract for preserving a newborn's U-Cord(TM) stem cells is obtained by SCPT at the full CRYO-CELL charge of $275, SCPT will receive a $25 commission.) 2. CCEL agrees to process and storage all of SCPT's clients' stem cells as follows: